Biobanks & Health Data Information Hub

  • EIT Health Scandinavia’s new Information Hub

    Designed to simplify for EIT Health Partners to access and establish collaborations, to leverage the innovation potential of these goldmines of information.

    Learn more
  • Prostate cancer test developed in record time thanks to biobank access

    Stockholm3 is a new blood-based test to predict the risk for aggressive prostate cancer. The Stockholm3 test reduces the number of unnecessary biopsies by 50%, and can also find aggressive cancer in men with low PSA values. It would have been impossible to develop the Stockholm3 test without access to large patient registers and biobanks.

    Learn more
  • Are you an Innovator? Why use biobanks and registers?

    Are you a start-up, innovator or researcher? Via health data registers and biobanks you can shorten time-to-market through product validation, cost-benefit analysis, impact prediction and access to expertise.

    Welcome to find out more!

    Learn more
  • Join our initiative!

    As a biobank or register owner, you will get increased exposure, knowledge of industry needs, increased use of samples and data, and possible sources of revenue.

    Welcome to find out more!

    Learn more
  • Cost-benefit analysis: how biobanks and health data add value

    Biobanks and health data registers provided an unmatched resource when performing a cost-benefit analysis for new healthcare treatments or protocols. Find out more about using these goldmines of information.

     

    Learn more

We support your ambitions!

Scandinavia’s and Estonia’s biobanks and health data registries are rich sources of human sample collections and patient data, complemented by world-class expertise and services. EIT Health Scandinavia wants to support the Partners’ ambitions to collaborate with biobanks and health data registers owned by other Partners for their projects. The new information hub is designed to simplify for the Partners to access biobanks and health data registers, and make it easier to establish productive collaborations that will help shape the future of healthcare and translational medicine.